Overview

A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers

Status:
Completed
Trial end date:
2010-04-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the irritation level of tazarotene foam after 21 days of exposure on the skin of healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Stiefel, a GSK Company
Collaborator:
GlaxoSmithKline
Treatments:
Nicotinic Acids
Tazarotene